Kyverna Therapeutics(KYTX) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Kyverna Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results EMERYVILLE, Calif., May 14, 2024 – Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, today reported its business highlights and financial results for the first quarter ended March 31, 2024. "We continue to build momentum in the clinical development of our lead pro ...